肝硬化患者腹水感染與血清降鈣素原的相關(guān)性分析
[Abstract]:Objective To investigate the correlation between ascites infection and serum procalcitonin (PCT) in patients with cirrhosis and to provide reference for the diagnosis of ascites infection in cirrhosis.Methods 50 patients with viral hepatitis and ascites bacterial peritonitis who were treated in hospital from April 2013 to April 2015 were selected as experimental group and 50 patients with viral hepatitis and ascites were not infected. Patients with infection were taken as control group. Ascites samples of test group were collected for bacterial culture, identification and drug susceptibility test. Serum PCT, polymorphonuclear leukocyte (PMN) and white blood cell (WBC) were detected in both groups. The positive rate of bacterial culture in ascites, the distribution of serum PCT test results, and the changes of PTC concentration in each period were observed. A total of 133 pathogenic bacteria were isolated from the water samples, 52 of them were Gram-positive bacteria (39.10%), 65 of them were Gram-negative bacteria (48.87%), 15 of them were fungi (11.28%) and 1 of them was acid-fast bacilli (0.75%). The results of PTC, PMN and WBC in the serum of the experimental group were significantly higher than those of the control group (P 0.05), and the PCT in the serum was 0.5 ng/ml as the positive limit, while the blood was 0.5 ng/ml as the positive limit. The sensitivity of serum PCT to the diagnosis of peritonitis was 96.00%. The control group was all negative. With the intervention of treatment, ascites infection was improved in the experimental group, and the serum PCT level was also decreased, while the serum PCT level in the control group was not significantly changed. Sensitivity has a high clinical reference value for the diagnosis and treatment of cirrhosis patients with ascites infection. In the treatment of cirrhosis patients with ascites infection, it is necessary to select reasonable antibiotics, and timely bacterial culture and drug sensitivity test.
【作者單位】: 重慶醫(yī)科大學(xué)附屬永川醫(yī)院消化內(nèi)科;重慶醫(yī)科大學(xué)附屬永川醫(yī)院感染科;
【基金】:重慶市衛(wèi)生局基金資助項(xiàng)目(2012-2-177)
【分類號(hào)】:R575.2
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 郭云霞;;肝硬化自發(fā)性細(xì)菌性腹膜炎腹水感染的細(xì)菌分布及耐藥性分析[J];中國實(shí)用醫(yī)藥;2013年21期
2 郭長青,黃宏春,李繼昌,寧寒冰;肝硬化自發(fā)性腹水感染患者腸通透性檢測(cè)的臨床意義[J];中華內(nèi)科雜志;2004年07期
3 胡琳琳;黃宏春;;肝硬化自發(fā)性腹水感染患者腸通透性檢測(cè)的臨床意義[J];中原醫(yī)刊;2006年14期
4 丁熠;陳金聯(lián);朱金水;;肝硬化患者腹水感染致病菌菌譜變化與藥敏分析[J];世界華人消化雜志;2006年10期
5 黨燕;于艷華;劉新;張立麗;陳銘;婁金麗;;血清降鈣素原和內(nèi)毒素在肝硬化患者腹水感染中的診斷價(jià)值[J];首都醫(yī)科大學(xué)學(xué)報(bào);2014年04期
6 周子成;江正輝;;自發(fā)性細(xì)菌性腹膜炎[J];遼寧醫(yī)學(xué)雜志;1988年03期
7 卜昕;張文瑾;范振平;何衛(wèi)平;蔡少平;吉英杰;;肝硬化并發(fā)自發(fā)性細(xì)菌性腹膜炎患者腹水感染161例的細(xì)菌種類及耐藥分析[J];中華臨床醫(yī)師雜志(電子版);2012年13期
8 張春平;肝硬化患者腸細(xì)菌過度生長為自發(fā)性腹水感染的一個(gè)因素?[J];國外醫(yī)學(xué)(內(nèi)科學(xué)分冊(cè));2003年12期
9 李勝軍;;舒普深腹腔注藥治療嚴(yán)重肝病腹水感染的效果觀察[J];現(xiàn)代診斷與治療;2014年06期
10 章文華;陳鑒;程海燕;沈哲;;肝硬化并發(fā)自發(fā)性腹膜炎患者腹水感染的細(xì)菌分布及耐藥性分析[J];中華醫(yī)院感染學(xué)雜志;2013年24期
相關(guān)會(huì)議論文 前1條
1 許青田;;腹水超濾濃縮回輸治療肝硬化頑固性腹水[A];第7屆全國疑難及重癥肝病大會(huì)論文集[C];2013年
,本文編號(hào):2213140
本文鏈接:http://sikaile.net/yixuelunwen/xiaohjib/2213140.html